In the News
September 23, 2020
Yarui Diao, Ph.D. received a U01 grant, totaling $3 million in research funding for 5 years, from 4D Nucleome Consortium (phase 2) through the NIH Common fund. Diao aims to determine the function and regulation of high-order chromatin structure on gene regulation and [...]
September 16, 2020 | Duke University
September 9, 2020
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, selected Yarui Diao to receive 2020 Genomic Innovator Awards. NHGRI honored a total of 12 early career investigators in genomics.
September 1, 2020 | Duke School of Medicine
June 22, 2020 | Development
Ken Poss recently joined the Development team as associate editor, focusing on the field of regenerative biology. Development interviewed him to find out more about his career, research, and why he decided to get involved with the journal.
June 19, 2020
Yarui Diao is trying to shed more light on rhabdomyosarcoma in an effort to come up with better treatment options.
April 21, 2020 | Duke Research Blog
Dr. Carin reflects on how Duke's fundamental research can turn viruses into marvels.
March 31, 2020
By Alissa Kocer A cancer patient and his family sit in a doctor’s office waiting to see how well he is responding to treatment. As the doctor pulls up his scans, all of the air in the room seems to vanish. When the doctor says, “Your tumor has shrunk and is almost gone!” A [...]
March 5, 2020
Four CAGT faculty are represented in the 2020 MEDxColloquia Awards. These colloquia are designed to bring together physicians, engineers, computer scientists, data analysts, and basic and/or clinical researchers with a desire to pursue an interdisciplinary approach to solve complex problems and inspire innovation in medicine.
February 28, 2020
Center for Advanced Genomic Technologies Steering Committee Members Maria Ciofani and Kris Wood have recently been awarded tenure. Congratulations to you both!
January 2, 2020 | Duke Engineering News
Collaborative work using CRISPR genome editing to address the burden of genetic neuromuscular diseases flourishes across Duke.
December 13, 2019 | Duke Engineering News
Combining a skin-level glass window with a gut-stabilizing magnet, researchers get a view into the colon of a live animal
November 19, 2019
Each year, the Web of Science Group identifies the world’s most influential researchers. The select few who have been most frequently cited by their peers over the last decade. In 2019, fewer than 6,300, or 0.1%, of the world's researchers, across 21 research fields, have [...]
November 15, 2019 | BioSpace
Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, will collaborate to develop in vivo AAV-based therapies for up to eight central nervous system and neuromuscular targets.
November 4, 2019 | Duke Engineering News
A Q&A with Charles Gersbach
October 14, 2019 | Duke GCB News
DARPA recently awarded a grant to a Duke team for a multifaceted research effort aimed at temporarily regulating gene expression using RNA-based techniques that could help protect against pandemic flu by boosting lung resistance to the virus, attacking the virus directly, enhancing the immune system response and improving the effects of existing vaccines.
September 30, 2019 | Duke Engineering News
Spanning Duke University and Duke Health, the Center for Advanced Genomic Technologies will use homegrown tools and techniques to discover potential therapies for human diseases from autism to cancer to schizophrenia
September 23, 2019 | Duke Engineering News
In a recent study, Charles Gersbach and Adrian Oliver, a post-doctoral fellow in the Gersbach lab who led the project, describe how they successfully harnessed Class 1 CRISPR systems to turn target genes on and off and edit the epigenome in human cells for the first time.
April 23, 2019 | Illumina
Celldom, cofounded by Kris Wood, Zachary Forbes, and Bejamin Yellen, is a research tools company developing next generation, single-cell analysis technology to advance research and drug discovery and development by illuminating diversity in cell populations.
April 15, 2019 | Duke Engineering News
An added piece of RNA could improve the precision of CRISPR 50-fold.
February 26, 2019 | NIH Director's Blog
The Gersbach lab's latest work on gene editing for Duchenne Muscular Dystrophy was highlighted in the NIH Director's Blog.
February 18, 2019 | Duke Engineering News
Genetic edits and protein restoration in mouse models of Duchenne muscular dystrophy remain viable one year after single CRISPR treatment.
January 1, 2019 | The Scientist
Using CRISPR and other tools, the Gersbach lab and other researchers are modifying DNA methylation, histone marks, and other modifiers of gene expression to understand how they affect health and disease.